| waist-hip ratio adjusted for BMI |
phenotype |
2 |
1 |
WHR adjusted for BMI |
| waist-to-hip ratio |
phenotype |
6 |
3 |
WHR |
| Wakefulness |
phenotype |
3 |
2 |
awake state |
| Wales |
cohort |
2 |
— |
|
| Walters et al., 2018 |
cohort |
2 |
— |
|
| warfarin |
drug |
4 |
1 |
|
| warmth |
phenotype |
3 |
3 |
E1: Warmth, expressions of warmth |
| wash buffer |
drug |
5 |
1 |
|
| Washington University |
cohort |
3 |
2 |
Washington University (St Louis, MO) |
| Washington University School of Medicine in St. Louis |
cohort |
2 |
2 |
|
| water |
drug |
38 |
12 |
distilled water, tap water, water, water control |
| water intake |
phenotype |
6 |
4 |
|
| wave 2 |
cohort |
23 |
15 |
2003 fall, 2003 spring, NESARC Wave 2, W1, W2, Wave 4 assessment, Waves 4, Waves 5, first wave, retest interview, wave 1 |
| WDR6 |
gene |
2 |
2 |
WD Repeat Domain 6, WD repeat domain 6 |
| weaning weight |
phenotype |
2 |
1 |
weaning weights |
| Wechsler Abbreviated Scale of Intelligence |
drug |
4 |
1 |
WASI |
| weight gain |
phenotype |
10 |
8 |
BW gain, gain weight, growth spurt, increase in weight, weight, weight gain |
| weight loss |
phenotype |
9 |
7 |
lose weight, weight loss |
| weight regulation |
phenotype |
2 |
1 |
|
| Wellcome Trust case control consortium |
cohort |
15 |
6 |
WTCCC |
